Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Equity (2021 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Return on Equity data on record, last reported at 1.01% in Q4 2025.

  • For Q4 2025, Return on Equity fell 45.0% year-over-year to 1.01%; the TTM value through Dec 2025 reached 1.01%, down 45.0%, while the annual FY2025 figure was 0.86%, 39.0% down from the prior year.
  • Return on Equity reached 1.01% in Q4 2025 per MRVI's latest filing, down from 0.6% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.96% in Q2 2021 and bottomed at 1.01% in Q4 2025.
  • Average Return on Equity over 5 years is 0.12%, with a median of 0.13% recorded in 2023.
  • Peak YoY movement for Return on Equity: increased 19bps in 2022, then crashed -73bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.94% in 2021, then plummeted by -40bps to 0.56% in 2022, then crashed by -129bps to 0.16% in 2023, then plummeted by -236bps to 0.55% in 2024, then tumbled by -82bps to 1.01% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 1.01% in Q4 2025, 0.6% in Q3 2025, and 0.68% in Q2 2025.